AZN vs MRK
AstraZeneca PLC · Merck & Company Inc
Relative return (rebased to 100)
Key stats
| Metric | AZN | MRK |
|---|---|---|
| Price | $186.65 | $149.52 |
| Market Cap | $289.31B | $368.89B |
| P/E | 28.29 | 20.21 |
| P/B | 5.94 | 8.80 |
| P/S | 4.93 | 5.67 |
| ROE | 21.0% | 43.5% |
| Net Margin | 17.4% | 28.1% |
| Gross Margin | 81.9% | — |
| Revenue Growth | 8.6% | 1.3% |
| Dividend Yield | 1.68% | 2.19% |
| EPS | $6.60 | $7.40 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.